Gout: diagnosis and management-summary of NICE guidance.
2022
Julie Neilson, and
Alexandra Bonnon, and
Alastair Dickson, and
Edward Roddy, and
National Institute for Health and Care Excellence, Piccadilly Plaza, Manchester M1 4BT, UK Julie.neilson@nice.org.uk.
UI
MeSH Term
Description
Entries
D006073
Gout
Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
Gouts
D006074
Gout Suppressants
Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.